Route Development toward a Pyrazine Building Block to Enable Early Scale-Up Campaigns
- 3 November 2025
- journal article
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 29 (11) , 2823-2833
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Preclinical Toxicology Supply for a Complex API Enabled by Asymmetric Catalysis and Rapid Chemical Development: IL-17A Inhibitor LY3509754Organic Process Research & Development, 2025
- An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)Journal of Medicinal Chemistry, 2024
- First Deliveries of API Enabling Early Drug DevelopmentOrganic Process Research & Development, 2024
- Improved Substrate Scope in the Potassium Hexacyanoferrate(II)-Based Cyanation for the Synthesis of Benzonitriles and Their Heterocyclic AnaloguesThe Journal of Organic Chemistry, 2018
- Discovery of 5-Azaindazole (GNE-955) as a Potent Pan-Pim Inhibitor with Optimized BioavailabilityJournal of Medicinal Chemistry, 2017
- The Necessary Nitrogen Atom: A Versatile High-Impact Design Element for Multiparameter OptimizationJournal of Medicinal Chemistry, 2017
- Synthesis and biological evaluation of heteroaryl styryl sulfone derivatives as anticancer agentsBioorganic & Medicinal Chemistry Letters, 2016
- Benzoxaborole Antimalarial Agents. Part 4. Discovery of Potent 6-(2-(Alkoxycarbonyl)pyrazinyl-5-oxy)-1,3-dihydro-1-hydroxy-2,1-benzoxaborolesJournal of Medicinal Chemistry, 2015
- A General, Practical Palladium‐Catalyzed Cyanation of (Hetero)Aryl Chlorides and BromidesAngewandte Chemie International Edition, 2013
- Acid‐Catalyzed In Situ Generation of Less Accessible or Unprecedented N‐Boc Imines from N‐Boc AminalsAngewandte Chemie International Edition, 2013